In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants
Annals of Internal Medicine · 2023
DOI: 10.7326/j23-0053 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Alexander P Benz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada, University Medical Center Mainz, Johannes Gutenberg-University,…. Hauptthemen laut MEDLINE: Anticoagulants, Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada, University Medical Center Mainz, Johannes Gutenberg-University, Mainz, Germany (A.P.B.).
- Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (J.W.E.).
Zitieren
APA
Benz, A. P., & Eikelboom, J. W. (2023). In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants. Annals of Internal Medicine. https://doi.org/10.7326/j23-0053
Vancouver
Benz AP, Eikelboom JW. In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants. Annals of Internal Medicine. 2023. doi:10.7326/j23-0053
BibTeX
@article{Benz2023,
author = {Benz, Alexander P and Eikelboom, John W},
title = {In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/j23-0053}
}
EUVIMED